Oramed initiates Phase 3 Trial of Oral Insulin

Oramed announced that ORMD-0801 is the first oral insulin capsule to achieve the requisite efficacy and safety data enabling them to run the world's first FDA approved phase 3 oral insulin trials in patients with type 2 diabetes who have inadequate glycaemic control

Source:

Biospace Inc.